Alector, Inc. (ALEC)
2.71
-0.01
(-0.37%)
USD |
NASDAQ |
Sep 03, 11:36
Alector Price : 2.71 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 2.40 | 2.76 | 2.40 | 2.72 | 1.673M |
| Sep 01, 2026 | 2.24 | 2.486 | 2.22 | 2.40 | 482394.0 |
| Aug 31, 2026 | 2.32 | 2.35 | 2.23 | 2.26 | 610060.0 |
| Aug 28, 2026 | 2.39 | 2.44 | 2.315 | 2.34 | 542222.0 |
| Aug 27, 2026 | 2.44 | 2.50 | 2.39 | 2.39 | 706964.0 |
| Aug 26, 2026 | 2.38 | 2.515 | 2.26 | 2.46 | 996494.0 |
| Aug 25, 2026 | 2.32 | 2.455 | 2.28 | 2.36 | 558276.0 |
| Aug 24, 2026 | 2.36 | 2.465 | 2.29 | 2.30 | 738145.0 |
| Aug 21, 2026 | 2.28 | 2.37 | 2.20 | 2.36 | 728095.0 |
| Aug 20, 2026 | 2.40 | 2.46 | 2.185 | 2.26 | 662589.0 |
| Aug 19, 2026 | 2.245 | 2.525 | 2.155 | 2.43 | 3.756M |
| Aug 18, 2026 | 2.04 | 2.30 | 2.04 | 2.21 | 4.774M |
| Aug 17, 2026 | 1.91 | 2.09 | 1.90 | 2.05 | 913808.0 |
| Aug 14, 2026 | 2.04 | 2.07 | 1.945 | 1.96 | 649021.0 |
| Aug 13, 2026 | 2.15 | 2.15 | 1.98 | 2.04 | 1.295M |
| Aug 12, 2026 | 2.06 | 2.175 | 2.02 | 2.15 | 786197.0 |
| Aug 11, 2026 | 1.68 | 2.129 | 1.65 | 2.09 | 5.543M |
| Aug 10, 2026 | 1.77 | 1.78 | 1.60 | 1.69 | 805595.0 |
| Aug 07, 2026 | 1.84 | 2.00 | 1.74 | 1.78 | 1.247M |
| Aug 06, 2026 | 1.49 | 2.035 | 1.482 | 1.83 | 5.704M |
| Aug 05, 2026 | 1.56 | 1.57 | 1.46 | 1.49 | 392306.0 |
| Aug 04, 2026 | 1.51 | 1.61 | 1.51 | 1.54 | 407157.0 |
| Aug 03, 2026 | 1.51 | 1.54 | 1.455 | 1.51 | 359923.0 |
| Jul 31, 2026 | 1.62 | 1.62 | 1.485 | 1.51 | 548295.0 |
| Jul 30, 2026 | 1.52 | 1.67 | 1.51 | 1.62 | 453154.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 84.95 |
| Oncolytics Biotech, Inc. | 0.871 |
| Sangamo Therapeutics, Inc. | 0.171 |
| Sarepta Therapeutics, Inc. | 22.76 |
| Anixa Biosciences, Inc. | 3.13 |
Price Related Metrics
| PS Ratio | 21.21 |
| Earnings Yield | -40.30% |
| Market Cap | 302.59M |